Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
HIV/AIDS Diagnostics
Rapid HIV and HIV/hepatitis C tests being registered internationally
September 14th, 2005
MedMira Inc. (MIR, MMIRF) announced that it is registering its rapid HIV and combination HIV/hepatitis C (HCV) tests in an additional 24 markets around the world. These new registrations will significantly boost the company's market presence and add new revenue streams. MedMira is currently registered and actively selling products in over a dozen major markets including the United States, China, South Africa, and Canada. In conjunction with product registrations, MedMira has established a network of qualified distributors or agents in each country. Registrations vary in complexity and length depending on the requirements in each country or region....
Source: Vaccine Weekly (2005-09-14)
|
